
Invited Speakers
Program
-
Thursday, 12 May, 2022
08:00-09:00
Registration and Assembly
Opening Remarks and Greetings
09:00-09:30
Dr. Pia Raanani, Head Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Israel
Dr. Eytan Wirtheim, CEO, Rabin Medical Center, Israel
Dr. Martin Ellis, Chairman, The Israeli Society of Hematology & Transfusion Medicine, Israel
Dr. Ehud Grossman, Dean, The Sackler Faculty of Medicine at Tel Aviv University, Israel
Dr. Gal Markel, Head, Davidoff Cancer Center, Rabin Medical Center, Israel
Session A
09:30-10:20
Cure in Acute Leukemias – Making the Dream a Reality…
Chairperson: Dr. Yishai Ofran
09:30-09:50 - The Elusive Goal of Cure in AML
Dr. Richard Stone, Dana Farber Institute, Boston, USA
09:50-10:10 - Are We Moving Towards a Chemo/Transplant-Free Era for Adult Ph+ ALL
Dr. Robin Foà, 'La Sapienza' University of Rome, Italy
10:10-10:20 - Panel Discussion

Session B
10:30-11:50
Cure in CML – Making the Dream a Reality…
Chairperson: Dr. Itai Levi
10:30-10:50 - How Can We Improve the Cure Rate in CML?
Dr. Giuseppe (Beppe) Saglio, University of Turin, Italy
10:50-11:05 - CML – A Differential Age Adjusted Approach for Cure
Dr. Pia Raanani, Davidoff Cancer Center, Rabin Medical Center, Israel
11:05-11:20 - Cure in CML - Patients' Perspective
Mr. Giora Sharf, Expert Patient Advocate, Israel
11:20-11:40 - Curing CML: To Be Or Not To Be, That is the Question
Dr. François-Xavier Mahon, Institut Bergonié, Université de Bordeaux, France
11:40-11:50 - Panel Discussion
Coffee Break
11:50--12:05
Session C
12:10-14:00
Cure of Lymphoproliferative Disorders - Making the Dream a Reality…
Chairperson: Dr. Tamar Tadmor
12:10-12:25 - Nipping CLL in the Bud – Strategies for Treatment of Early CLL
Dr. Gilad Itchaki, Davidoff Cancer Center, Rabin Medical Center, Israel
12:25-12:45 - Chronic Lymphocytic Leukemia: Treatment Development Towards Cure or Real Chronic Disease?
Dr. Barbara Eichhorst, University Hospital of Cologne, Germany
12:45-13:05 - The New Targeted Therapies in CLL: Better Alone or in Combination?
Dr. Jan Burger, University of Texas MD Anderson Cancer Center, USA
13:05-13:25 - Primary Mediastinal Lymphoma: It is Possible to Cure a Subset of R/R Patients With Checkpoints Inhibitors?
Dr. Pierre Luigi Zinzani, University of Bologna, Bologna, Italy
13:25-13:40 - Peripheral T Cell Lymphoma - On the Way to Cure…?
Dr. Ronit Gurion, Davidoff Cancer Center, Rabin Medical Center, Israel
13:40-14:00 - Panel Discussion

14:00-14:45
Lunch Break
Session D
14:45-15:50
Cure of Myeloproliferative Disorders - Making the Dream a Reality…
Chairperson: Dr. Martin Ellis
14:45-15:05 - Targeted Treatment in Rare Chronic Myeloid Neoplasms
Dr. Andreas Reiter, Universitätsmedizin Mannheim, Mannheim, Germany
15:05-15:20 - Cure in Myelofibrosis – Are We Already There 2022?
Dr. Adi Shacham-Abulafia, Davidoff Cancer Center, Rabin Medical Center, Israel
15:20-15:40 - Aetas Ipsa Est Morbus: Myeloid Malignancies, Inflammation and Aging
Dr. Michael Deininger, Versiti Blood Research Institute, Medical College of Wisconsin, USA
15:40-15:50 - Panel Discussion
Session E
16:00-16:45
Cure of Plasma Cell Disorders - Making the Dream a Reality…
Chairperson: Dr. Moshe Gatt
16:00-16:20 - Pathway to Cure of Multiple Myeloma
Dr. Morie Gertz, Mayo Clinic Minnesota, USA
16:20-16:35 - Aiming for Cure for AL Amyloidosis
Dr. Iuliana Vaxman, Davidoff Cancer Center, Rabin Medical Center, Israel
16:35-16:45 - Panel Discussion
Session F
16:50-17:45
Cure in Hemato-oncology: The End of the Beginning…
Chairperson: Dr. Jacob Rowe & Dr. Moshe Yeshurun

16:50-17:20 - The Potential Cure of All (most) Leukemias in the Next Decade: An Optimist’s Vision
Dr. Hagop Kantarjian, University of Texas MD Anderson Cancer Center, USA
17:20-17:40 - The "Cure Panel" – Round Table
All Speakers
17:40-17:45 - Closing Remarks
Friday, 13 May, 2022
09:00-12:00- Round Table Symposium
Meet the Experts(s): Cure in Ph (+) and Ph (-) myeloproliferative disorders: A present goal or future aspiration?...
Participants:
-
Dr. Robin Foà, 'La Sapienza' University of Rome, Italy
-
Dr. Giuseppe (Beppe) Saglio, University of Turin, Italy
-
Dr. Pia Raanani, Davidoff Cancer Center, Rabin Medical Center, Israel
-
Mr. Giora Sharf, Expert Patient Advocate, Israel
-
Dr. François-Xavier Mahon, Institut Bergonié, Université de Bordeaux, France
-
Dr. Andreas Reiter, Universitätsmedizin Mannheim, Mannheim, Germany
-
Dr. Adi Shacham-Abulafia, Davidoff Cancer Center, Rabin Medical Center, Israel
-
Dr. Michael Deininger, Versiti Blood Research Institute, Medical College of Wisconsin, USA
-
Dr. Itai Levi, Soroka Medical Center, Israel
-
Dr. Martin Ellis, Meir Medical Center, Israel